EMEA-002933-PIP01-20
Key facts
| Active substance |
Single strain of non-genetically modified Prevotella histicola (EDP1815)
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0008/2022
|
| PIP number |
EMEA-002933-PIP01-20
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of psoriasis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Evelo Biosciences, Inc.
+1 6175770300 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|